Literature DB >> 3085106

Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.

L O Andersson, N Forsman, K Huang, K Larsen, A Lundin, B Pavlu, H Sandberg, K Sewerin, J Smart.   

Abstract

Human factor VIII has been isolated from a high purity factor VIII concentrate by immunoaffinity chromatography and HPLC on Mono Q gel. Two fractions of factor VIII were obtained with a specific activity of approximately equal to 7000 units/mg. The major fraction contained eight peptide chains of 200, 180, 160, 150, 135, 130, 115, and 105 kDa plus one doublet chain of 80 kDa. The minor fraction contained one peptide chain of 90 kDa plus the chain of 80 kDa. Both fractions were activated by thrombin to the same extent. Amino-terminal amino acid sequence analysis was performed on the 180-kDa, 130-kDa, and 90-kDa chains and showed an identical amino-terminal sequence in these chains. Each chain from 200 kDa to 90 kDa was linked to one 80-kDa chain by a metal-ion bridge(s). Studies on factor VIII in plasma and cryoprecipitate, prepared and gel filtered in the presence of protease inhibitors, showed that one 200-kDa plus one 80-kDa chain were the only or dominating chains in the materials and may represent native factor VIII. The results indicated that all chains from 180 kDa to 90 kDa are fragments of the 200-kDa chain. All of these more or less fragmented chains form active factor VIII complexes with the 80-kDa chain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3085106      PMCID: PMC323430          DOI: 10.1073/pnas.83.9.2979

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  THE ACTIVATION OF ANTIHEMOPHILIC FACTOR (FACTOR 8) BY ACTIVATED CHRISTMAS FACTOR (ACTIVATED FACTOR9 9).

Authors:  R L LUNDBLAD; E W DAVIE
Journal:  Biochemistry       Date:  1964-11       Impact factor: 3.162

2.  Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and to factor IX.

Authors:  B Osterud; S I Rapaport
Journal:  Biochemistry       Date:  1970-04-14       Impact factor: 3.162

3.  Structure of human factor VIII.

Authors:  G A Vehar; B Keyt; D Eaton; H Rodriguez; D P O'Brien; F Rotblat; H Oppermann; R Keck; W I Wood; R N Harkins; E G Tuddenham; R M Lawn; D J Capon
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

4.  Molecular cloning of a cDNA encoding human antihaemophilic factor.

Authors:  J J Toole; J L Knopf; J M Wozney; L A Sultzman; J L Buecker; D D Pittman; R J Kaufman; E Brown; C Shoemaker; E C Orr
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

5.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

6.  Sequence theories of blood coagulation re-evaluated with reference to lipid-protein interactions.

Authors:  P G Barton
Journal:  Nature       Date:  1967-09-30       Impact factor: 49.962

7.  Reaction sequence of blood coagulation.

Authors:  H C Hemker; M J Kahn
Journal:  Nature       Date:  1967-09-09       Impact factor: 49.962

8.  A study of the reaction product of factor 8 and factor IX by gel filtration.

Authors:  C Hougie; K W Denson; R Biggs
Journal:  Thromb Diath Haemorrh       Date:  1967-08-15

9.  Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies.

Authors:  F Rotblat; D P O'Brien; F J O'Brien; A H Goodall; E G Tuddenham
Journal:  Biochemistry       Date:  1985-07-30       Impact factor: 3.162

10.  Human factor VIII procoagulant protein. Monoclonal antibodies define precursor-product relationships and functional epitopes.

Authors:  C A Fulcher; J R Roberts; L Z Holland; T S Zimmerman
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

View more
  18 in total

1.  pH-dependent association of factor VIII chains: enhancement of affinity at physiological pH by Cu2+.

Authors:  Hironao Wakabayashi; Qian Zhou; Keiji Nogami; Charles Ansong; Fatbardha Varfaj; Stephen Miles; Philip J Fay
Journal:  Biochim Biophys Acta       Date:  2006-04-22

2.  Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain.

Authors:  N Bihoreau; P Paolantonacci; C Bardelle; M P Fontaine-Aupart; S Krishnan; J Yon; J L Romet-Lemonne
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

3.  Expression of human coagulation factor VIII in a human hybrid cell line, HKB11.

Authors:  Baisong Mei; Yaoqi Chen; Jianmin Chen; Clark Q Pan; John E Murphy
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

4.  Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation.

Authors:  H J Brinkman; P Koster; K Mertens; J A van Mourik
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

5.  Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry.

Authors:  J Spaargaren; P L Giesen; M P Janssen; J Voorberg; G M Willems; J A van Mourik
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

Review 6.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

7.  Contribution of factor VIII light-chain residues 2007-2016 to an activated protein C-interactive site.

Authors:  Masahiro Takeyama; Hironao Wakabayashi; Philip J Fay
Journal:  Thromb Haemost       Date:  2012-12-06       Impact factor: 5.249

8.  Variable contributions of basic residues forming an APC exosite in the binding and inactivation of factor VIIIa.

Authors:  Masahiro Takeyama; Jennifer M Wintermute; Chandrashekhara Manithody; Alireza R Rezaie; Philip J Fay
Journal:  Biochemistry       Date:  2013-03-22       Impact factor: 3.162

9.  The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.

Authors:  A Leyte; J Voorberg; H B Van Schijndel; B Duim; H Pannekoek; J A Van Mourik
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

10.  Intracellular retention of a factor VIII protein with an Arg2307-->Gln mutation as a cause of haemophilia A.

Authors:  J Voorberg; R T de Laaf; P M Koster; J A van Mourik
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.